We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZBAO:NASDAQZhibao Technology Inc. Analysis

Data as of 2026-06-24 - not real-time

$0.46

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Zhibao Technology is trading just above its recent support level, with the 20‑day SMA sitting below the 50‑day SMA, confirming a bearish price structure. The 14‑day RSI is deep in oversold territory, while the MACD line remains under the signal line, reinforcing short‑term downside pressure. Volume has been on a decreasing trend, and the 30‑day volatility exceeds 100%, indicating a highly erratic price environment. Fundamentals are mixed: revenue grew more than 40% year‑over‑year, yet the company posted a negative profit margin, operating losses and a negative ROE, while debt exceeds equity by a wide margin. Cash reserves are modest relative to total debt, and free cash flow is positive only after accounting for large operating cash outflows. The DCF‑derived fair value is dramatically higher than the current market price, suggesting a massive valuation gap. However, the lack of dividend payments and the company’s negative earnings profile raise concerns about sustainability. The sector – insurance brokerage in China – carries heightened regulatory scrutiny, and the company’s exposure to the Chinese market adds geographic and currency considerations. Market sentiment, as reflected by an “Extreme Greed” reading on the fear‑greed index, may be driving speculative interest despite the weak fundamentals. Overall, the stock appears deeply discounted but is burdened by operational and financial challenges that could limit upside.
Investors should weigh the substantial upside potential against the pronounced downside risks, including liquidity constraints, regulatory headwinds, and the company’s ongoing loss‑making status. A cautious stance is warranted, with any exposure justified only by a belief in a turnaround or a significant improvement in profitability.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • price hovering at support with decreasing volume
  • bearish technical signals (SMA crossover, MACD, RSI)
  • high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • strong revenue growth but persistent losses
  • substantial valuation discount to DCF estimate
  • ongoing regulatory and debt concerns

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • potential upside if profitability improves
  • large gap between market price and fair value
  • exposure to expanding digital insurance market in China

Key Metrics & Analysis

Financial Health

Revenue Growth40.70%
Profit Margin-19.52%
ROE-99.67%
ROA-11.02%
Debt/Equity111.55
P/B Ratio5.2
Op. Cash Flow$-107109984
Free Cash Flow$52.5M
Industry P/E17.0

Technical Analysis

TrendBearish
RSI26.6
Support$0.46
Resistance$1.14
MA 20$0.69
MA 50$0.74
MA 200$0.89
MACDBearish
VolumeDecreasing
Fear & Greed Index86.36

Valuation

Fair Value$54.53
GradeUndervalued
TypeBlend

Risk Assessment

Beta-0.13
Volatility117.60%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.